Showing 2,791 results

Filters Content type: News, Editors' picks Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP science

Widespread support for HIV PrEP among infectious disease doctors in the US and Canada

News
17 December 2013
PrEP

Gay Men Having More Unprotected Sex, but Truvada has Changed Game

Editor's pick
New Republic
16 December 2013
Treatment guidelines

Australia: Treatment as prevention, what do we think?

Editor's pick
NAPWA
2 December 2013
HIV prevention policy

HIV Prevention, Young Gay Men of Color and the Fourth Wave of HIV Activism

Editor's pick
The Body
22 November 2013
Vaginal rings & topical PrEP

AAPS showcases vaginal ring with tenofovir + contraceptive, gel suitable for vaginal and rectal use

Editor's pick
HIVandHepatitis.com
21 November 2013
Vaginal rings & topical PrEP

Novel microbicide gel for vagina and rectum shows potential for HIV prevention

Editor's pick
Eurekalert Inf Dis
15 November 2013
Undetectable viral load & treatment as prevention

How Do You Talk About It? Two Guys Take On “Undetectable”

Editor's pick
BETA blog
13 November 2013
Vaginal rings & topical PrEP

HIV Microbicides Require Safety, Efficacy, Good Marketing

Editor's pick
Medscape (requires free registration)
30 October 2013
Vaginal rings & topical PrEP

IPM Receives Two Awards from USAID to Advance HIV Prevention Technologies for Women

Editor's pick
International Partnership for Microbicides
22 October 2013
HIV prevention policy

Action on HIV in Australia - Melbourne Declaration update

Editor's pick
NAPWHA
17 October 2013
PrEP

HIV protective drugs 'do not increase sexual risk-taking'

Editor's pick
Medical News Today
17 October 2013
Vaginal rings & topical PrEP

Researchers and advocates discuss the microbicides pipeline in Europe

News
17 October 2013
PrEP

PrEP: Information and Speculation

Editor's pick
Vada
10 October 2013
PrEP

Long-Acting HIV Antiretrovirals May Be Revolutionary. But Will They Be Worth It?

Editor's pick
The Body Pro
6 October 2013
PrEP

David Evans: PrEP Should Be a Fast Idea, Not a Slow One

Editor's pick
Huffington Post
5 October 2013
PrEP science

New integrase inhibitor GSK1265744 safe and well tolerated in eight studies

News
4 October 2013
Vaginal rings & topical PrEP

Microbicide ring study shows users are reassured about discomfort but develop new worries about safety

News
3 October 2013
Vaginal rings & topical PrEP

Researchers launch first-ever phase II safety study of rectal microbicide to prevent HIV

Editor's pick
Eurekalert Inf Dis
3 October 2013
PrEP

What’s next for PrEP in the UK?

Editor's pick
Incidence 0
2 October 2013
PrEP

Why Is No One On the First Treatment To Prevent HIV?

Editor's pick
New Yorker (blog)
2 October 2013
PrEP policies & guidelines

Who will PrEP be for?

News
1 October 2013
Vaginal rings & topical PrEP

Tenofovir vaginal ring protects monkeys on Depo-Provera against HIV-like virus

News
30 September 2013
PrEP science

Uptake of PrEP may be limited because few gay men think they are at risk of HIV infection

News
27 September 2013
PrEP

PATH Evaluates Janssen’s Rilpivirine as HIV Infection Prophylactic

Editor's pick
Genetic Engineering & Biotechnology News
25 September 2013